275 related articles for article (PubMed ID: 2927618)
1. Growth of prolactinoma despite lowering of serum prolactin by bromocriptine.
Kupersmith MJ; Kleinberg D; Warren FA; Budzilovitch G; Cooper P
Neurosurgery; 1989 Mar; 24(3):417-23. PubMed ID: 2927618
[TBL] [Abstract][Full Text] [Related]
2. Visual function improvement in patients with macroprolactinomas treated with bromocriptine.
Lesser RL; Zheutlin JD; Boghen D; Odel JG; Robbins RJ
Am J Ophthalmol; 1990 May; 109(5):535-43. PubMed ID: 2333917
[TBL] [Abstract][Full Text] [Related]
3. A giant prolactinoma and the effect of chronic bromocriptine therapy on basal and TRH-stimulated serum prolactin levels.
Barrera CM; Ruiz AE; Banks WA
Horm Res; 1991; 35(3-4):167-9. PubMed ID: 1806471
[TBL] [Abstract][Full Text] [Related]
4. Rapid re-enlargement of a macroprolactinoma after initial shrinkage in a young woman treated with bromocriptine.
Adler I; Barsi P; Czirják S; Varga I; Gergics P; Jakab C; Rácz K
Gynecol Endocrinol; 2005 Jun; 20(6):317-21. PubMed ID: 16019380
[TBL] [Abstract][Full Text] [Related]
5. Giant prolactinomas: clinical management and long-term follow up.
Shrivastava RK; Arginteanu MS; King WA; Post KD
J Neurosurg; 2002 Aug; 97(2):299-306. PubMed ID: 12186457
[TBL] [Abstract][Full Text] [Related]
6. [Treatment of prolactin-secreting pituitary tumors with bromocriptine].
Katzir D; Rosenberg T; Ramot Y; Gaver-Shavit A; Gilboa Y
Harefuah; 1990 Feb; 118(3):141-5. PubMed ID: 2341064
[TBL] [Abstract][Full Text] [Related]
7. Hyperprolactinaemia in males: a heterogeneous disorder.
Walsh JP; Pullan PT
Aust N Z J Med; 1997 Aug; 27(4):385-90. PubMed ID: 9448878
[TBL] [Abstract][Full Text] [Related]
8. MR volumetry for monitoring intramuscular bromocriptine treatment in macroprolactinomas.
Benesch H; Felber SR; Finkenstedt G; Kremser C; Stockhammer G; Aichner FT
J Comput Assist Tomogr; 1995; 19(6):866-70. PubMed ID: 8537517
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis and drug therapy of prolactinoma.
Ciccarelli E; Camanni F
Drugs; 1996 Jun; 51(6):954-65. PubMed ID: 8736617
[TBL] [Abstract][Full Text] [Related]
10. [Morphological changes in prolactinoma induced by bromocriptine treatment].
Scanarini M
Minerva Endocrinol; 1990; 15(1):13-5. PubMed ID: 2274009
[TBL] [Abstract][Full Text] [Related]
11. Long-acting bromocriptine for the acute treatment of large macroprolactinomas.
Zarate A; Moran C; Miranda R; Loyo M; Medina M; Fonseca ME
J Endocrinol Invest; 1987 Jun; 10(3):233-6. PubMed ID: 3624799
[TBL] [Abstract][Full Text] [Related]
12. Long-term efficacy of bromocriptine in macroprolactinomas and giant prolactinomas in men.
Chattopadhyay A; Bhansali A; Masoodi SR
Pituitary; 2005; 8(2):147-54. PubMed ID: 16379032
[TBL] [Abstract][Full Text] [Related]
13. Prolactinoma in an adolescent girl: unusual response to bromocriptine therapy.
Tiwary CM
Am J Dis Child; 1989 May; 143(5):521-3. PubMed ID: 2718982
[No Abstract] [Full Text] [Related]
14. [Long-term bromocriptine treatment of giant prolactinoma: report of a case].
Mashio Y; Beniko M; Ikota A; Mizumoto H; Sato S; Yamaguchi O; Suzuki S; Tashiro T; Ikota T
Nihon Naika Gakkai Zasshi; 1989 Dec; 78(12):1785-6. PubMed ID: 2625603
[No Abstract] [Full Text] [Related]
15. Withdrawal of bromocriptine after long-term therapy for macroprolactinomas; effect on plasma prolactin and tumour size.
van 't Verlaat JW; Croughs RJ
Clin Endocrinol (Oxf); 1991 Mar; 34(3):175-8. PubMed ID: 2036725
[TBL] [Abstract][Full Text] [Related]
16. Treatment with long acting repeatable bromocriptine (Parlodel-LAR*) in patients with macroprolactinomas: long-term study in 29 patients.
Jamrozik SI; Bennet AP; James-Deidier A; Tremollieres F; Saint-Martin F; Dumoulin S; Valat-Coustols M; de Glisezinski I; Tremoulet M; Manelfe C; Louvet JP
J Endocrinol Invest; 1996; 19(7):472-9. PubMed ID: 8884542
[TBL] [Abstract][Full Text] [Related]
17. Prolactin-secreting macroadenomas in adolescents. Response to bromocriptine therapy.
Tyson D; Reggiardo D; Sklar C; David R
Am J Dis Child; 1993 Oct; 147(10):1057-61. PubMed ID: 8213676
[TBL] [Abstract][Full Text] [Related]
18. Clinical practice. Prolactinomas.
Klibanski A
N Engl J Med; 2010 Apr; 362(13):1219-26. PubMed ID: 20357284
[No Abstract] [Full Text] [Related]
19. Parlodel LAR in the treatment of macroprolactinomas.
Kocijancic A; Prezelj J; Vrhovec I; Lancranjan I
Acta Endocrinol (Copenh); 1990 Feb; 122(2):272-6. PubMed ID: 2316314
[TBL] [Abstract][Full Text] [Related]
20. Macroprolactinomas: serial MR imaging in long-term bromocriptine therapy.
Lundin P; Bergström K; Nyman R; Lundberg PO; Muhr C
AJNR Am J Neuroradiol; 1992; 13(5):1279-91. PubMed ID: 1414816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]